Isabel Buccellati
Isabel Buccellati

Isabel Buccellati

Senior Equity Analyst

Fundos relacionados

23 Julho 2020

Article II

Global investors underappreciate the changing behaviour of Japanese companies, which has made them more resilient and well positioned to benefit from global reflation.
Read time - 5 min
20 Maio 2020

Pharmaceutical companies in a golden age for drug discovery

As new technologies such as genomics spur development of innovative drugs, European pharmaceuticals companies stand out as high-quality, defensive growth stocks.
Tempo de leitura - 5 min

Fundos relacionados

23 Julho 2020

Isabel Buccellati

Senior Equity Analyst

Article II

Global investors underappreciate the changing behaviour of Japanese companies, which has made them more resilient and well positioned to benefit from global reflation.
Read time - 5 min
20 Maio 2020

Isabel Buccellati

Senior Equity Analyst

Pharmaceutical companies in a golden age for drug discovery

As new technologies such as genomics spur development of innovative drugs, European pharmaceuticals companies stand out as high-quality, defensive growth stocks.
Tempo de leitura - 5 min
Load more articles